Mizoshita, T., Katano, T., Tanida, S., Hirano, A., Miyaki, T., Ozeki, K., . . . Joh, T. (2017). Prospective comparison of preference and efficacy of adalimumab and infliximab for treating ulcerative colitis naive to antitumor necrosis factor therapy. Medicine (Baltimore).
Citación estilo ChicagoMizoshita, Tsutomu, et al. "Prospective Comparison of Preference and Efficacy of Adalimumab and Infliximab for Treating Ulcerative Colitis Naive to Antitumor Necrosis Factor Therapy." Medicine (Baltimore) 2017.
Cita MLAMizoshita, Tsutomu, et al. "Prospective Comparison of Preference and Efficacy of Adalimumab and Infliximab for Treating Ulcerative Colitis Naive to Antitumor Necrosis Factor Therapy." Medicine (Baltimore) 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.